Merck & Co. has agreed to acquire Cidara Therapeutics for approximately $9.2 billion, the companies said, in a deal designed to bolster the buyer’s antiviral portfolio with a Phase III drug designed ...
Sunday. Post-lunch. The atmosphere was pure, low-grade tension. Write or stroll. That was the whole setup. The writing urge was bugging me; the whole day an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback